EverPoint Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

EverPoint Asset Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12.8M	Hold	70,000	–	–	0.24%	113
2016 Q3	$11.5M	Hold	70,000	–	–	0.21%	127
2016 Q2	$10M	Buy	+70,000	New	+$9.98M	0.2%	147
2016 Q1	–	Sell	-100,000	Closed	-$13.9M	–	423
2015 Q4	$13.9M	Buy	100,000 +10,000	+11%	+$1.39M	0.29%	107
2015 Q3	$12.1M	Buy	+90,000	New	+$13M	0.31%	87

Other funds holding BIO

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

EverPoint Asset Management's BIO Position: Q4 2016 in Review

EverPoint Asset Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q4 2016 at 70,000 shares worth $12.8M. The position accounts for 0.24% of the portfolio, ranked #113.

EverPoint Asset Management first reported a position in BIO in Q3 2015 and has held it in 5 quarters since. The position peaked at $13.9M in Q4 2015. 261 funds tracked by Wall St. Rank hold BIO as of Q4 2016.

EverPoint Asset Management held 70,000 shares of Bio-Rad Laboratories Class A worth $12.8M as of Q4 2016.
EverPoint Asset Management left its Bio-Rad Laboratories Class A share count unchanged in Q4 2016.
Bio-Rad Laboratories Class A made up 0.24% of EverPoint Asset Management's portfolio in Q4 2016, its #113 holding.
EverPoint Asset Management first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and has held it in 5 quarters since.
EverPoint Asset Management's Bio-Rad Laboratories Class A position peaked at $13.9M in Q4 2015.
261 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.